Deucravacitinib, a TYK2 inhibitor, safety in psoriasis and psoriatic arthritis: What should a dermatologist know?

• Váldodahkkit: Inês Pereira Amaral (Dahkki), Joana Antunes (Dahkki), Ivânia Soares (Dahkki), Madalena Pupo Correia (Dahkki), Paulo Filipe (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2023-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Fuomášahttimat

2768-6566
10.1002/jvc2.132